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ABSTRACT
Background and Objectives: Whether using both traditional risk factors and genetic variants 
for stroke as opposed to using either of the 2 alone improves the prediction of stroke risk 
remains unclear. The purpose of this study was to compare the predictability of stroke risk 
between models using traditional risk score (TRS) and genetic risk score (GRS).
Methods: We used a case-cohort study from the Korean Cancer Prevention Study-II (KCPS-II) 
Biobank (n=156,701). We genotyped 72 single nucleotide polymorphisms (SNPs) identified 
in genome-wide association study (GWAS) on the KCPS-II sub-cohort members and stroke 
cases. We calculated GRS by summing the number of risk alleles. Prediction models with or 
without GRS were evaluated in terms of the area under the receiver operating characteristic 
curve (AUROC).
Results: Sixteen out of 72 SNPs identified in GWAS showed significant associations with 
stroke, with an odds ratio greater than 2.0. For participants aged <40 years, AUROCs for 
incident stroke were 0.58, 0.65, and 0.67 in models using modifiable TRS only, GRS only, and 
TRS plus GRS, respectively, showing that GRS only model had better prediction than TRS 
only. For participants aged ≥40 years, however, TRS only model had better prediction than 
GRS only model. Favorable levels of traditional risk were associated with significantly lower 
stroke risks within each genetic risk category.
Conclusions: TRS and GRS were both independently associated with stroke risk. Using 
genetic variants in addition to traditional risk factors may be the most accurate way of 
predicting stroke risk, particularly in relatively younger individuals.
Keywords: Risk factors; Epidemiologic methods; Genetics; Stroke
INTRODUCTION
Stroke is the third leading cause of death and disability in Korea as well as worldwide.1) 
Approximately 9% of total deaths are attributable to stroke-related causes, and the crude death 
rate of Koreans due to stroke was 48.2 per 100,000 persons in 2014. Moreover, the annual 
medical cost for stroke accounts for more than 10% of the total medical expenditures in Korea.1)2)
Estimating absolute risk of stroke typically relies on prediction models developed using 
data from prospective cohort studies. Numerous previous studies have identified a 
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variety of traditional risk factors for stroke using standard ways of establishing prediction 
models including multivariate functions.3-5) More recent studies have evaluated whether 
incorporating nontraditional risk factors (e.g., genetic variants) into models with traditional 
risk factors improves the accuracy of predicting stroke risk, but, it has shown only limited 
improvement in the overall prediction accuracy.6-8)
The rapid growth in genome-wide association study (GWAS) has resulted in the discovery 
of common genetic variants associated with stroke. This has enabled researchers to develop 
stroke risk prediction models using genetic variants identified in GWAS of stroke,9)10) but 
the predictive validity of the models appears inconclusive. It may be due, in large part, to 
the possibility that genetic variants identified in GWAS of stroke may reflect the effect of 
modifiable traditional risk factors (e.g., hypertension, diabetes, dyslipidemia, and smoking), 
as well as the direct genetic effects on stroke.11) Furthermore, most of the identified genetic 
variants not only have small effects on stroke risk, but also are associated with modifiable 
traditional risk factors for stroke.12) An alternative approach to improve predictability is to use 
genetic variants that are known to have large effect sizes and are unrelated to established risk 
factors for stroke.13)
Another issue with standard prediction modeling approaches is measurement errors 
associated with the quantification of traditional risk factors. If measurement errors for 
traditional risk factors exist, the predictability of prediction models using such factors tends 
to be reduced. A genetic risk score (GRS) is an approach that can potentially overcome the 
issue with large measurement errors.14)15) Nevertheless, there is few research using these 
approaches altogether in developing and evaluating prediction models for stroke risk.
The aim of this study was, therefore, to develop prediction models for stroke risk using 
genetic variants that are known to have relatively large effect sizes (e.g., odds ratios [ORs] 
greater than 2.0) and unrelated to established risk factors for stroke. We also compared the 
predictability of stroke risk between models using traditional risk factors, GRS, and both 
traditional factors and GRS.
METHODS
Study subjects
The Korean Cancer Prevention Study-II (KCPS-II) Biobank was initiated in April 2004. It 
was supported by the Seoul City Government in December 2005 as a project of the Korean 
Metabolic Syndrome Research Initiatives study. A full description of KCPS-II has been 
previously published.15)16) We have acquired written consent forms and blood samples from 
156,701 participants. Among the total 156,701 participants, 1,047 participants who reported 
having a prevalent stroke were excluded. In addition, 12,107 participants who had missing 
values on systolic blood pressure, fasting blood glucose, total cholesterol, smoking status, 
and exercise were excluded. During the follow-up through December 2011, identified 823 (out 
of 144,594 participants) were recorded as incident cases of stroke. These data were used to 
develop both GWAS and prediction models.
For the case-cohort study, we selected a sub-cohort as a 3.4% random sample of all participants. 
Twenty-seven out of 4,856 randomly-selected participants were found to be diagnosed with 
stroke from our sub-cohort study, while 796 stroke cases were verified outside the sub-cohort.
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In short, we included a total of 5,656 additional participants (4,833 plus 823 participants) in 
our case-cohort study design. The Institutional Review Board of Yonsei University reviewed and 
approved this study (approval No. 4-2011-0277). All participants have submitted an informed 
consent form at baseline survey.
Traditional risk factors
To develop prediction models using traditional risk factors, we first fitted Cox proportional 
hazards regression models to a basic set of classical risk factors: age, sex, hypertension, 
diabetes, dyslipidemia, and smoking status.
DNA extraction and single nucleotide polymorphism (SNP) analysis
The blood samples for DNA extraction used in the current study were obtained from the KCPS-
II Biobank at baseline. We conducted genotyping in 2016, using a randomly selected sub-cohort 
of KCPS-II Biobank. Genotype data were produced using the Korean Chip (K-CHIP) obtained 
from the K-CHIP consortium. K-CHIP was designed by Center for Genome Science, Korea 
National Institute of Health, Korea (4845-301, 3000-3031). Seventy-four SNP were identified 
in GWAS of stroke in this study (Supplementary Table 1). Among the seventy-four SNPs, there 
were sixteen final SNPs, and cluster QC was successful (Supplementary Figure 2).
Outcome variables
Stroke events, comprising the occurrence of death due to stroke or the first occurrence of 
nonfatal stroke, were recorded.3) We identified the events from insurance claims reported 
to the National Health Insurance System (NHIS). Since the NHIS is a national organization, 
follow-up was expected to be 100% completed. We ascertained nonfatal or stroke events, 
defined according to the International Classification of Diseases 10th revision (ICD-10, I60–
I69) revision, from health insurance claims data from the NHIS. Cases of fatal stroke (ICD-10, 
I60–I69) were ascertained from the causes of death listed on death certificates.
We conducted a validation study in collaboration with the NHIS (formally Korean Medical 
Insurance Corporation). For participants who provided written permission for the use of 
their personal informations, 626 stroke events between 1993 and 1997 were confirmed with 
individual hospital medical records, and 83% of the stroke cases were validated.17)
Statistical analysis
To evaluate the general characteristics of the study participants, we calculated means and 
standard deviations (SDs), and presented proportions of hypertension, diabetes, dyslipidemia, 
and cigarette smoking status. We calculated GRS by summing the number of risk alleles over all 
SNPs. We then categorized the GRS into tertiles. Stroke risk associated with any one genotype 
was estimated as an OR and 95% confidence interval (CI), and was computed using logistic 
regression under an additive genetic model. We also used the area under the receiver operating 
characteristic curve (AUROC) analysis. Finally, Cox proportional hazards models were used to 
estimate the effect of GRS and traditional risk score (TRS) on stroke risk.
RESULTS
Table 1 describes the characteristics of the sub-cohort controls and stroke cases at their first 
health examination at baseline. Stroke cases were older and had higher systolic blood pressure, 
fasting glucose, and total cholesterol levels than the sub-cohort controls. Also, stroke cases 
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were more likely to have hypertension, diabetes, and dyslipidemia at baseline. Smoking status 
and exercise levels did not differ between the sub-cohort controls and stroke cases.
Table 2 shows 16 SNPs among 72 SNPs identified from GWAS with an OR of 2 or greater. 
Among the 16 SNPs used in the GRS calculation, 4 SNPs were associated with the brain 
function (rs56680016 in CADPS gene, rs141824980 in GNB5 gene) and with dyslipidemia 
(rs191810437 in GPAT3 gene, rs188932107 in SOX5 gene). Four SNPs (rs12115631, rs142764455, 
rs147074671, and rs147154581) out of the 72 SNPs had stroke-related risk genes (PTPRD, DLG2, 
TPK1, and GCLC) (data not shown).
Table 3 shows prediction models for specific types of stroke using traditional risk scoring 
and count or weighted genetic-risk scoring. The AUROC value was highest in ischemic stroke 
(0.83) than hemorrhagic stroke (0.68). However, there were no differences between model 1 
with count GRS, and model 2 with weighed GRS.
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Table 1. General characteristics of study participants, in case-cohort design
Variables Sub-cohort Total stroke p value
Participants number 5,263 823 (625)*
Age (years) 43.1 (9.3) 52.4 (11.5) <0.001
Systolic blood pressure (mmHg) 118.3 (14.2) 125.4 (15.9) <0.001
Fasting blood glucose (mg/dL) 90.7 (18.4) 98.2 (26.1) <0.001
Total cholesterol (mg/dL) 189.9 (33.3) 197.3 (35.3) <0.010
LDL cholesterol (mg/dL) 113.8 (31.3) 117.6 (33.1) <0.001
HDL cholesterol (mg/dL) 50.9 (10.0) 50.1 (11.5) 0.068





Sex (female) 33.4 32.3 0.672
Hypertension 17.9 42.7 <0.001
Diabetes 4.9 14.8 <0.001
High cholesterol 34.2 44.3 <0.001
Data shown are mean (SD) or percentage (%).
HDL = high-density lipoprotein; LDL = low-density lipoprotein; SD = standard deviation.
*The number in parenthesis is incident.
Table 2. Allelic ORs for stroke in study participants
SNPs* Chromosome Gene RA RAF HR (95% CI)
(24) rs17002646 22 ME11 C 1.0 2.2 (1.5–3.3)
(30) rs56680016 3 CADPS† C 1.4 2.5 (1.8–3.6)
(34) rs75053900 10 FAM208B C 98.0 2.6 (1.8–3.8)
(35) rs77412933 16 LOC107984901 A 1.4 2.5 (1.8–3.6)
(37) rs79159085 7 LOC221946 C 1.8 2.4 (1.7–3.3)
(38) rs79789141 1 - C 98.0 2.6 (1.8–3.8)
(44) rs117868687 8 - G 1.6 2.0 (1.2–2.5)
(48) rs139580491 15 - C 97.0 2.1 (1.6–2.8)
(52) rs141824980 15 GNB5† C 1.3 2.9 (2.0–4.1)
(55) rs143387922 9 - C 98.0 2.1 (1.5–3.0)
(57) rs144579871 3 LOC105374257 A 98.0 2.0 (1.3–3.0)
(63) rs149912751 2 - A 1.1 2.2 (1.5–3.4)
(67) rs191810437 4 GPAT3‡ A 1.2 3.1 (2.1–4.4)
(70) rs141886475 17 - C 97.0 2.6 (1.3–5.2)
(71) rs184999606 13 RCBTB2 G 98.0 2.9 (1.4–6.0)
(72) rs188932107 12 SOX‡ G 98.0 2.8 (1.4–5.6)
CI = confidence interval; HR = hazard ratio; OR = odds ratio; RA = risk allele; RAF = risk allele frequency; SNP = single nucleotide polymorphism.
*Parentheses represent the SNP number in Supplementary Table 1; †These 2 genes are related to brain function; ‡These 2 genes are related to dyslipidemia.
Table 4 shows whether modifiable risk factors and GRS improve the prediction of stroke 
risk beyond age and sex, as determined by AUROC. We evaluated data according to different 
age groups. For participants aged <40 year at baseline, AUROCs (95% CI) for modifiable 
traditional risk factors (model 1), GRS only (model 2), and model 1 plus GRS (model 3) 
were 0.58 (model 1), 0.65 (model 2), and 0.67 (model 3) for incident stroke, respectively. 
Compared to model 1, the AUROC improved by 7% in model 2, and 9% in model 3. However, 
the predictability decreased in model 2 among participants aged 40 years and older.
Figure 1 shows AUROCs for incident stroke according to the different age groups. The gene-
environment risk score model showed significant improvements in predictability by about 9% 
compared with the TRS model for the young-stroke risk category, while negligible differences 
were observed for old-stroke and even all stroke models. Favorable traditional risk was 
significantly associated with lower stroke risk within each genetic risk category (Figure 2).
Supplementary Figure 1 and Supplementary Table 2 showed age-specific comparisons of 
HRs for GRS-stroke associations between logistic and Cox proportional hazard models. 
The association was highest among participants aged 50 to 59 years, but lowest among 
participants aged 60 years and older.
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Table 3. Stroke type specific prediction models using TRS and count or weighted GRS, multiple logistic model
Variables Total stroke (823/5,266) Ischemic stroke (356/5,730) Hemorrhagic stroke (216/5,870)
Model 1 Model 2 Model 1 Model 2 Model 1 Model 2
Age (years) 0.08 (<0.01) 0.08 (<0.01) 0.09 (<0.01) 0.09 (<0.01) 0.02 (<0.01) 0.02 (<0.01)
Sex 0.14 (0.23) 0.13 (0.11) −0.01 (0.97) −0.01 (0.93) −0.27 (0.18) −0.28 (0.17)
Hypertension 0.69 (<0.01) 0.69 (<0.01) 0.71 (<0.01) 0.71 (<0.01) 0.50 (<0.01) 0.50 (<0.01)
Diabetes 0.46 (<0.01) 0.46 (<0.01) 0.67 (<0.01) 0.67 (<0.01) 0.25 (0.28) 0.25 (0.28)
Dyslipidemia 0.19 (0.02) 0.19 (0.02) 0.15 (0.20) 0.15 (0.21) 0.15 (0.29) 0.15 (0.31)
Ex-smokers −0.01 (0.91) −0.01 (0.93) 0.22 (0.21) 0.22 (0.22) 0.01 (0.94) 0.01 (0.95)
Current smokers 0.28 (0.02) 0.28 (0.02) 0.46 (0.01) 0.45 (0.01) 0.27 (0.15) 0.27 (0.16)
Count GRS 0.80 (<0.01) 0.74 (<0.01) 0.50 (<0.01)
Weighted GRS 1.04 (<0.01) 0.98 (<0.01) 0.65 (<0.01)
AIC 4,016.79 4,015.44 2,174.24 2,172.52 2,172.52 1,804.18
AUROC 0.79 0.79 0.83 0.83 0.68 0.68
Data shown are β (p).
AIC = akaike information criterion; AUROC = area under the receiver operating characteristic curve; GRS = genetic risk score; TRS = traditional risk score.
Table 4. Total stroke prediction models, case-cohort design using Cox proportional hazard model
Variables
Age <40 years at baseline  
(104 cases/2,177 controls)




Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3
TRS
T1 1.0 1.0 1.0 1.0 1.0 1.0
T2 2.0 (1.3–3.0) 1.9 (1.3–2.9) 1.4 (0.8–2.8) 1.5 (0.8–2.9) 2.0 (1.5–2.7) 2.0 (1.5–2.7)
T3 6.6 (3.0–15) 8.0 (3.6–18) 6.0 (3.3–11) 6.4 (3.5–12) 8.4 (6.5–11) 8.5 (6.6–11)
GRS
G1 1.0 1.0 1.0 1.0 1.0 1.0
G2 2.6 (0.7–12) 2.8 (0.7–11) 1.9 (1.2–3.2) 2.1 (1.3–3.5) 2.0 (1.3–3.4) 2.2 (1.4–3.5)
G3 9.6 (2.3–39) 9.5 (2.3–39) 4.9 (2.9–8.1) 5.4 (3.3–9.0) 5.5 (3.4–8.9) 5.9 (3.7–9.5)
AIC 22,121.3 22,103.8 22,085.2 111,613.7 111,713.9 111,487.3 134,304.8 134,601.8 134,132.9
DF 2 2 4 2 2 4 2 2 4
AUROC 0.58 0.65 0.67 0.72 0.62 0.76 0.75 0.63 0.78
Δ Reference 0.07 0.09 Reference −0.10 0.04 Reference −0.12 0.03
TRS included age, sex, hypertension, diabetes, dyslipidemia, and smoking status; TRS was classified into tertile (T1, T2, T3). GRS included 16 SNPs using weighted 
method; GRS was classified into tertile (G1, G2, G3). AUROC was estimated using logistic model. Data shown are HR (95% CI).
AIC = akaike information criterion; AUROC = area under the receiver operating characteristic curve; CI = confidence interval; DF = degree of freedom; GRS = genetic 
risk score; HR = hazard ratio; SNP = single nucleotide polymorphism; TRS = traditional risk score.
DISCUSSION
This study aimed to determine whether the putative stroke risk alleles identified in GWAS 
exhibit higher predictive validity than traditional modifiable risk factors for stroke in Koreans. 
We found 16 of the 72 SNPs associated with stroke risk to have relatively big effect sizes (with 
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Figure 1. AUROC for incident stroke according to age groups. 















Figure 2. A favorable traditional risk for stroke according to genetic risk category.
During the 633,210 person-year follow-up period, 823 incident stroke cases developed. 
This case-cohort study evaluated the ability to predict risk based on TRS only, and TRS plus 
GRS, which aggregates information from 16 genetic variants shown to be associated with 
risk of stroke in Koreans. Most previous genetic epidemiology studies have focused on 
total stroke events (ischemic or hemorrhagic), but the present study evaluating ischemic 
and hemorrhagic stroke separately demonstrated relatively smaller improvements in 
predictability for hemorrhagic stroke compared with ischemic stroke.
Although a genetic contribution to stroke risk is well-known, it has been unclear if the 
genetic contribution is larger for young-onset stroke than for old-onset stroke, or vice versa.18) 
Moreover, it has been debatable whether a prediction model with genetic variants has higher 
predictability for young-onset stroke than for old-onset stroke. In this sense, this study 
provides important evidence that GRS for the putative stroke risk alleles identified from 
GWAS in Korean populations is predictive of incident stroke in conjunction with age, sex, 
and modifiable traditional risk factors. In particular, the contribution of GRS for the putative 
stroke risk alleles was much higher among younger participants aged less than 40 years old. 
Based on the recent evidence from European ancestry, heritabilities of young-onset stroke 
and old-onset stroke were estimated to be 42% (±8%, p<0.001) and 34% (±10%, p<0.001), 
respectively.18)19) These results indicate that genetic contributions to stroke vary by age. 
Performing large, well-powered GWAS using various ranges of age is needed to provide more 
definitive evidence on the associations.
The early onset of stroke is more likely to reflect relatively higher genetic effects.18) In our 
study, the AUROC for GRS was highest in participants with the early onset of stroke among 
the 3 groups of age (less than 40 years old, ages 40 to 59, and 60 years old and above). The 
mean ages of the 3 groups according to the age at the onset of stroke were 36.4, 50.7, and 66.9 
years, respectively (Figure 1). This suggests that the prediction models with traditional risk 
factors had limitations in predicting the early onset of stroke. Individuals with the early onset 
of stroke may be more accurately diagnosed using our models incorporating genetic variants.
Genetic variants identified in GWAS of stroke may reflect direct genetic effects on stroke, 
as well as the effect of modifiable risk factors, such as hypertension, diabetes, dyslipidemia 
and smoking. As we run larger GWAS, some of the signals that emerge may turn out to 
reflect the action of modifiable (e.g., environmental and/or behavioral) factors, rather than 
the more direct biological effects.11) If this is true, most genetic variants from GWAS would 
also reflect the action of the modifiable risk factors mentioned above. In such a case, these 
genetic variants would not help to improve the accuracy of prediction models because these 
modifiable risk factors would already be included in the prediction models as predictors. 
In other words, modifiable risk factors may act as biological intermediates between genetic 
variants and stroke in this study.
Another issue is that genetic variants identified in GWAS have only moderate effects and 
small contributions to the variance of outcome variables. As such, we found 74 SNPs to be 
associated with stroke in our initial GWAS of stroke. However, only 16 of the 74 SNPs had an 
OR greater than 2.0.
In the present study, among 16 SNPs used in the GRS calculation, 2 of them were associated 
with the brain (rs56680016 in CADPS gene, rs141824980 in GNB5 gene) and 2 other with 
dyslipidemia (rs191810437 in GPAT3 gene, rs188932107 in SOX5 gene). These genes were not 
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discovered previously in METASTROKE as reported in 2012.20) In addition, we evaluated 41 
SNPs reported by Traylor et al.20) in our GWAS, and found that the K-CHIP we used had 26 
SNPs, with 4 SNPs of them showing statistical significance with stroke (p<0.05).20)
In general, SNPs with relatively large effects are rare variants, while those with small effects 
are likely to be common variants. Eight of the 16 SNPs included in our stroke prediction 
models were rare variants. Therefore, these 8 SNP minor allele frequencies were very rare and 
should be combined with a heterozygous type. This approach might mislead the true mode of 
inheritance from codominant or additive mode to a recessive or a dominant mode. Therefore, 
our results need to be interpreted with caution.
In terms of measurement errors, the TRS estimated by traditional risk factors may have 
more measurement errors than the GRS. Repeated measures and biological variations of 
some traditional risk factors, such as blood pressure and fasting glucose, may help to reduce 
the measurement errors. In this study, in particular with younger age group of less than 40 
years old, the prediction model with GRS had a 9% higher predictability than the model 
with TRS.
A major limitation is the use of self-reported exposures collected at a single point in time, 
which precluded the definitive exclusion of potential misclassification. The statistical power 
of the current study is modest, as genotyping was performed on a limited sample size of 
stroke cases and controls. However, a notable strength of our study is the case-cohort design 
drawn from an underlying large prospective cohort. Furthermore, case identifications 
were performed by record linkage to the NHIS with verification, increasing the reliability 
of our information. Genetic studies tend to be confounded by linkage disequilibrium, so 
confounding by population stratification cannot be completely ruled out. To overcome 
this limitation, we used a multidimensional-scaling method for population stratification 
analysis,21) which did not separate out the cluster of our data using multidimensional-scaling. 
In addition, the majority of the Korean populations are ethnically homogenous, minimizing a 
negative effect.22)
In conclusion, models using both traditional and genetic risk factors showed improvements 
in stroke risk prediction compared with models using either of the 2 alone. Therefore, both 
traditional and genetic risk factors for stroke should be considered when predicting stroke 
risk, in particular in younger individuals for the prediction of the early onset of stroke.
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